Skip to content

Optimising the management of mental health problems in primary care

Optimising the effectiveness of the management of mental health problems in primary care using new technologies

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74799543
Enrollment
100
Registered
2020-01-22
Start date
2020-02-01
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mood [affective] disorders, Neurotic, stress-related and somatoform disorders Mental and Behavioural Disorders Mood [affective] disorders, Neurotic, stress-related and somatoform disorders

Interventions

Entry into the study will be offered to attendees at a nurse-led clinic for people who have mental health problems which will be set up in Nottingham, UK. The clinic will run at the student health cen

Sponsors

University of Nottingham
Lead Sponsor
P1vital Products Ltd
Collaborator
The MicroCurrent Site
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Attendance at nurse-led mental health clinic 2. Registered with participating general practice (this is necessary to ensure that clinical alerts generated by the ispero system can be acted upon in a timely manner) 3. Capacity to understand information sheet and provide informed consent

Exclusion criteria

Exclusion criteria: 1. Patients not suitable for the nurse-led mental health clinic. These would include those who appear distressed or at acute risk of harm to themselves or others or who appear to be intoxicated. The reception staff at the practice are already skilled in identifying these patients. The nurse-led clinic would also not be suitable for those with mental health problems related to a terminal or acute physical illness. 2. Those unable to communicate effectively in English

Design outcomes

Secondary

MeasureTime frame
Satisfaction as measured by questionnaire at 8 weeks

Primary

MeasureTime frame
Improvements from baseline to 8-weeks in I-spero data (I-spero uses a number of validated tests and an AI algorithm to monitor response to treatment)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026